---
title: "BioKangtai: Trivalent influenza virus split vaccine approved for clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253413238.md"
description: "BioKangtai and Lanzhou Bailing Biotechnology Co., Ltd. have jointly developed a trivalent influenza virus split vaccine, which has received clinical trial approval from the National Medical Products Administration. The vaccine is suitable for individuals aged 3 and above and aims to prevent influenza caused by the influenza virus. The company plans to conduct clinical trials as soon as possible, and if successful, it will enhance the company's market competitiveness"
datetime: "2025-08-18T08:04:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253413238.md)
  - [en](https://longbridge.com/en/news/253413238.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253413238.md)
generator: "portal-rs"
---

# BioKangtai: Trivalent influenza virus split vaccine approved for clinical trials

BioKangtai announced that recently, the trivalent influenza virus split vaccine developed by the company and Lanzhou Bailing Biotechnology Co., Ltd. has received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration. This vaccine is suitable for individuals aged 3 years and older and can stimulate the body to produce immunity against the influenza virus, used for the prevention of influenza caused by vaccine-related strains. The company will promptly carry out relevant clinical trial work. If the vaccine development is successful, it will help further enrich the company's product layout and enhance its core competitiveness and market position

### Related Stocks

- [300601.CN](https://longbridge.com/en/quote/300601.CN.md)

## Related News & Research

- [14:56 ETMimi's Cafe Launches Fall Menu With Pumpkin Spice, Freshly Baked Biscuits, and More Seasonal Specials](https://longbridge.com/en/news/297222710.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [Gama Aviation urges UK HEMS, police operators to start ESN aircraft upgrade planning ahead of 2028 deadline](https://longbridge.com/en/news/297064854.md)
- [Bioretec hosts media event highlighting 500,000 Activa bioresorbable orthopedic implants sold worldwide](https://longbridge.com/en/news/297047388.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**